Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active, Moderate to Severe Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableEnded earlyNCT01464021
What this trial is testing

A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

Who this might be right for
ArthritisRheumatoid
AbbVie (prior sponsor, Abbott) 26
Large-scale testing (Phase 3)Study completedNCT00951275
What this trial is testing

Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 105
Testing effectiveness (Phase 2)Study completedNCT05848258
What this trial is testing

An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 164
Post-approval studies (Phase 4)Looking for participantsNCT07554820
What this trial is testing

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Who this might be right for
Rheumatoid ArthritisMajor Adverse Cardiac Events
Shaikh Zayed Hospital, Lahore 120
Large-scale testing (Phase 3)UnknownNCT05725434
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 30
Large-scale testing (Phase 3)Study completedNCT01256736
What this trial is testing

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
JW Pharmaceutical 89
Testing effectiveness (Phase 2)Study completedNCT06800157
What this trial is testing

Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Shanghai Longwood Biopharmaceuticals Co., Ltd. 72
Very early researchLooking for participantsNCT07001956
What this trial is testing

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Large-scale testing (Phase 3)Study completedNCT02889796
What this trial is testing

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 1,759
Large-scale testing (Phase 3)Study completedNCT01232569
What this trial is testing

RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 656